Abbott Laboratories (ABT) Revenue — Quarter Ended Mar 31, 2023
Abbott Laboratories reported a decline in revenue for the quarter. The decrease was present both sequentially from the immediately preceding quarter and compared to the same quarter one year earlier.
Key takeaway
Quarter ended Mar 31, 2023 · FY2023 Q1
Abbott Laboratories reported a decline in revenue for the quarter. The decrease was present both sequentially from the immediately preceding quarter and compared to the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$9.7B
Revenue reported for this quarter.
Quarter-over-quarter
-3.4%
Change from the immediately preceding quarter.
Year-over-year
-18.1%
Change from the comparable year-ago quarter.
Trailing four quarters
$41.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2022 | $11.3B | +10.1% |
| Sep 30, 2022 | $10.4B | -4.7% |
| Dec 31, 2022 | $10.1B | -12.0% |
| Mar 31, 2023 | $9.7B | -18.1% |
Revenue performance
Revenue moved lower, continuing a downward trend observed over the past several quarters.
Quarterly comparison
Compared to the prior quarter, revenue fell, and the year-over-year comparison showed a larger decline.
What to watch
The company has now posted three consecutive quarterly revenue declines, marking a noteworthy pattern.